News + Filings Holdings
All
13F
13D/G
Other
|
|
CAXTON CORP
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/14/2023 |
SC 13G/A
| CAXTON CORP reports a 5% stake in Rezolute, Inc. |
| 02/14/2023 |
SC 13G/A
| CAXTON CORP reports a 2.2% stake in Cardiff Oncology, Inc. |
| 02/14/2023 |
SC 13G/A
| CAXTON CORP reports a 0.9% stake in Addex Therapeutics Ltd |
| 02/14/2023 |
SC 13G/A
| CAXTON CORP reports a 4.4% stake in Xeris Biopharma Holdings, Inc. |
| 02/14/2022 |
SC 13G/A
| CAXTON CORP reports a 8.1% stake in Cardiff Oncology, Inc. |
| 02/14/2022 |
SC 13G/A
| CAXTON CORP reports a 9% stake in SCYNEXIS, Inc. |
| 02/14/2022 |
SC 13G/A
| CAXTON CORP reports a 6% stake in Addex Therapeutics Ltd |
| 02/14/2022 |
SC 13G/A
| CAXTON CORP reports a 8.6% stake in Rezolute, Inc. |
| 02/14/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2022 |
SC 13G/A
| CAXTON CORP reports a 6.1% stake in Savara Inc. |
| 02/16/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/16/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/16/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/16/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/16/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2020 |
SC 13G/A
| CAXTON CORP reports a 0% stake in Investcorp Credit Management BDC, Inc. |
| 02/14/2019 |
SC 13G/A
| CAXTON CORP reports a 7.5% stake in CM Finance Inc |
| 02/14/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 05/22/2018 |
SC 13G/A
| CAXTON CORP reports a 2% stake in Agile Therapeutics, Inc. |
| 02/14/2018 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2018 |
SC 13G/A
| CAXTON CORP reports a 5.3% stake in Agile Therapeutics, Inc. |
| 08/04/2017 |
SC 13G/A
| CAXTON CORP reports a 4.8% stake in Agile Therapeutics, Inc. |
| 02/06/2017 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals [Amend] |
|
|